Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-06

FDA Approved: ISOTRETINOIN — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for isotretinoin submitted by Actavis Pharma, Inc. The approval pertains to changes in labeling and/or indications f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

SUPPL AP for ISOTRETINOIN (ISOTRETINOIN)